Skip to main content

Bharat Biotech to launch Covaxin in Q2 2021

The company has received approval from the DCGI to conduct Phase-3 clinical trial to establish the efficacy of the vaccine candidate

from Business Line - Companies https://ift.tt/3jLvMxM

Comments

Popular posts from this blog